CAJ | 학술논문

自从2006年研究者利用重编程技术发现诱导多能干细胞（iPSCs）以来，iPSCs一度成为科学家们在干细胞领域研究的热点，这是继胚胎干细胞（ESCs）之后又一能够进行自体细胞移植、组织工程学研究、药物筛选、药物安全性检测研究和体外疾病模型研究等方面得到广泛应用的细胞来源。目前 iPSCs 应用于临床实践还有一段距离，但因其在再生医学方面的优势，在临床应用上有很好的应用前景。
자종2006년연구자이용중편정기술발현유도다능간세포（iPSCs）이래，iPSCs일도성위과학가문재간세포영역연구적열점，저시계배태간세포（ESCs）지후우일능구진행자체세포이식、조직공정학연구、약물사선、약물안전성검측연구화체외질병모형연구등방면득도엄범응용적세포래원。목전 iPSCs 응용우림상실천환유일단거리，단인기재재생의학방면적우세，재림상응용상유흔호적응용전경。
Researchers discovered induced pluripotent stem cells (iPSCs)by reprogramming technology in 2006.Since then,iPSCs became a hot issue in stem cell research field.It is another engineering cell source after the embryonic stem cells (ESCs),which can be applied in autologous cell transplantation,tissue en-gineering research,drug screening,drug safety testing research and disease model research in vitro .Al-though iPSCs have not been used in clinical currently,but with the advantages in the field of regenerative medicine,therefore has a great application prospect in clinical application.